HCA
Harbour Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,871
| Closed | -$1.23M | – | 251 |
|
|
2021
Q3 | $1.23M | Buy |
12,871
+1,285
| +11% | +$123K | 0.32% | 84 |
|
|
2021
Q2 | $1.13M | Buy |
11,586
+1,215
| +12% | +$118K | 0.3% | 91 |
|
|
2021
Q1 | $1.01M | Buy |
+10,371
| New | +$1.01M | 0.3% | 88 |
|
|
2020
Q4 | – | Sell |
-10,156
| Closed | -$977K | – | 151 |
|
|
2020
Q3 | $977K | Buy |
10,156
+1,450
| +17% | +$139K | 0.36% | 80 |
|
|
2020
Q2 | $1.06M | Buy |
8,706
+1,119
| +15% | +$137K | 0.43% | 69 |
|
|
2020
Q1 | $657K | Buy |
7,587
+4,607
| +155% | +$399K | 0.33% | 86 |
|
|
2019
Q4 | $320K | Buy |
+2,980
| New | +$320K | 0.12% | 162 |
|